Transgene S.A [TNG] vs Valneva SE [VLA] Detailed Stock Comparison
Transgene S.A
Euronext
Loading...
Valneva SE
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Transgene S.A wins in 5 metrics, Valneva SE wins in 11 metrics, with 0 ties. Valneva SE appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Transgene S.A | Valneva SE | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 70.64 | N/A |
| Price-to-Book Ratio | 10.61 | 3.40 | Valneva SE |
| Debt-to-Equity Ratio | 68.38 | 105.63 | Transgene S.A |
| PEG Ratio | -2.10 | -10.28 | Valneva SE |
| EV/EBITDA | -4.50 | -20.01 | Valneva SE |
| Profit Margin (TTM) | 0.00% | -34.15% | Transgene S.A |
| Operating Margin (TTM) | -639.52% | -22.01% | Valneva SE |
| Return on Equity | -220.48% | -38.02% | Valneva SE |
| Return on Assets (TTM) | -51.00% | -6.58% | Valneva SE |
| Free Cash Flow (TTM) | $-26.62M | $-83.66M | Transgene S.A |
| 1-Year Return | 15.09% | 35.23% | Valneva SE |
| Price-to-Sales Ratio (TTM) | 25.49 | 3.33 | Valneva SE |
| Enterprise Value | $154.69M | $668.64M | Valneva SE |
| EV/Revenue Ratio | 24.35 | 3.41 | Valneva SE |
| Gross Profit Margin (TTM) | N/A | 50.10% | N/A |
| Revenue per Share (TTM) | $0 | $1 | Valneva SE |
| Earnings per Share (Diluted) | $-0.29 | $-0.46 | Transgene S.A |
| Beta (Stock Volatility) | 0.81 | 1.01 | Transgene S.A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Transgene S.A vs Valneva SE Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Transgene S.A | 6.09% | 10.91% | 20.79% | 27.08% | 76.81% | 79.41% |
| Valneva SE | -2.16% | 2.70% | -4.04% | 39.71% | 16.92% | 64.50% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Transgene S.A | 15.09% | -45.05% | -10.95% | -58.22% | -83.10% | -83.10% |
| Valneva SE | 35.23% | -53.14% | -42.25% | 7.65% | -26.50% | -26.50% |
News Based Sentiment: Transgene S.A vs Valneva SE
Transgene S.A
News based Sentiment: MIXED
September saw significant stock price fluctuations for Transgene S.A., coupled with an upcoming financial results announcement on September 16th, 2025. While analyst ratings remain positive, the volatility introduces uncertainty, making this a crucial month for investors to assess the company's direction.
Valneva SE
News based Sentiment: MIXED
September presented a mixed bag for Valneva, with promising Lyme disease vaccine data offset by continued challenges with the IXCHIQ vaccine and its impact on revenue forecasts. While analyst sentiment remains generally positive, the IXCHIQ situation introduces significant uncertainty, making this a high-risk, high-reward investment.
Performance & Financial Health Analysis: Transgene S.A vs Valneva SE
| Metric | TNG | VLA |
|---|---|---|
| Market Information | ||
| Market Cap | €164.87M | €653.26M |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 190,797 | 1,306,252 |
| 90 Day Avg. Volume | 139,170 | 2,136,634 |
| Last Close | €1.22 | €3.80 |
| 52 Week Range | €0.53 - €1.38 | €1.73 - €5.41 |
| % from 52W High | -11.91% | -29.75% |
| All-Time High | €13.75 (Feb 10, 2014) | €29.70 (Nov 29, 2021) |
| % from All-Time High | -91.13% | -87.21% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | 0.27% |
| Quarterly Earnings Growth | 1.50% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | -0.34% |
| Operating Margin (TTM) | -6.40% | -0.22% |
| Return on Equity (TTM) | -2.20% | -0.38% |
| Debt to Equity (MRQ) | 68.38 | 105.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.12 | €1.12 |
| Cash per Share (MRQ) | €0.13 | €0.97 |
| Operating Cash Flow (TTM) | €-23,548,000 | €-11,900,000 |
| Levered Free Cash Flow (TTM) | €-19,767,000 | €-34,380,124 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Transgene S.A vs Valneva SE
| Metric | TNG | VLA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 70.64 |
| Forward P/E | -2.10 | -10.28 |
| PEG Ratio | -2.10 | -10.28 |
| Price to Sales (TTM) | 25.49 | 3.33 |
| Price to Book (MRQ) | 10.61 | 3.40 |
| Market Capitalization | ||
| Market Capitalization | €164.87M | €653.26M |
| Enterprise Value | €154.69M | €668.64M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 24.35 | 3.41 |
| Enterprise to EBITDA | -4.50 | -20.01 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 1.01 |
| Book Value per Share (MRQ) | €0.12 | €1.12 |
Financial Statements Comparison: Transgene S.A vs Valneva SE
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TNG | VLA |
|---|---|---|
| Revenue/Sales | €1.09M | €49.23M |
| Cost of Goods Sold | N/A | €23.04M |
| Gross Profit | N/A | €26.19M |
| Research & Development | €4.90M | €14.95M |
| Operating Income (EBIT) | €-4.93M | €-5.96M |
| EBITDA | €-4.93M | €-5.45M |
| Pre-Tax Income | €-4.88M | €-7.76M |
| Income Tax | €-176,764 | €1.47M |
| Net Income (Profit) | €-4.70M | €-9.23M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TNG | VLA |
|---|---|---|
| Cash & Equivalents | €16.67M | €152.99M |
| Total Current Assets | €20.67M | €287.05M |
| Total Current Liabilities | €13.98M | €106.20M |
| Long-Term Debt | N/A | €188.74M |
| Total Shareholders Equity | €15.20M | €175.25M |
| Retained Earnings | €-139.73M | €-573.16M |
| Property, Plant & Equipment | N/A | €154.31M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TNG | VLA |
|---|---|---|
| Operating Cash Flow | N/A | €-7.74M |
| Capital Expenditures | N/A | €-1.40M |
| Free Cash Flow | N/A | €-9.62M |
| Debt Repayment | N/A | €-685,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TNG | VLA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 190,797 | 1,306,252 |
| Average Daily Volume (90 Day) | 139,170 | 2,136,634 |
| Shares Outstanding | 132.74M | 162.40M |
| Float Shares | 34.92M | 126.75M |
| % Held by Insiders | 0.73% | 0.12% |
| % Held by Institutions | 0.01% | 0.23% |
Dividend Analysis & Yield Comparison: Transgene S.A vs Valneva SE
| Metric | TNG | VLA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |